A Prospective, Observational, Single-blinded, Longitudinal MRI Study of Effect of Glatiramer Acetate on Iron Deposition in Patients With Relapsing-remitting Multiple Sclerosis Over 24 Months
Latest Information Update: 27 Mar 2013
At a glance
- Drugs Glatiramer acetate (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- Acronyms GASWI
- 01 Feb 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Oct 2012 New trial record